Increased GPER expression was only observed in metastatic tumor samples of women who had been treated with tamoxifen, but not in metastases of women who were not prescribed tamoxifen, indicating a possible role for GPER in the development of relapse breast cancer [66]. This evidence concerns the gene GPER1 and metastatic neoplasm.